Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart Disease
NCT01099982
This study is recruiting at 3 US sites in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
Hypothesis: Tissue and serum samples collected from end-stage heart failure patients receiving left ventricular assist device implantation (LVAD) or heart transplantation will provide information regarding the basic science of heart disease. Tissue and serum samples collected from a limited numbers of "healthy controls" (donor grafts that were not utilized for heart transplantation) will serve as a comparator in research database projects. Design: This is a registry project; there are no investigational treatments, drug or procedures associated with participation in registry activities.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Congestive Heart Failure
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 13 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- University of Utah
- Last updated on ClinicalTrials.gov
- August 13, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Utah · 3
- Intermountain Medical Center · Murray, UT
- University of Utah Health Sciences Center · Salt Lake City, UT
- VA Salt Lake City Health Care System · Salt Lake City, UT
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.